Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More
Shazia K. Nakhoda, MD
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
About
Assistant Professor, Department of Hematology/Oncology
Hematology-Lymphoma Program
Treatment Focus
Malignant Hematology; Central Nervous System Lymphoma
Treatment Philosophy
Navigating a new cancer diagnosis can be challenging and overwhelming. I feel honored to be part of a team that provides patients and their families not only specialized oncologic care, but also the support and resources needed. The collaborative network of clinicians, nurses, and researchers at Fox Chase allows me to provide my patients individualized treatment options, novel therapies, and access to clinical trials. In addition, I strive to provide my patients and their families compassionate and comprehensive clinical care throughout each aspect of their journey.
Education and Training
Educational Background
- Hematology & Oncology Fellowship Training, Temple University and Fox Chase Cancer Center, Philadelphia, PA, 07/2017-06/2020
- Internal Medicine Residency Training, University of Maryland Medical Center, Baltimore, MD, 6/2014-06/2017
- MD, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, 2014
Certifications
American Board of Internal Medicine
Memberships
- American Society of Clinical Oncology
- American Society of Hematology
Honors & Awards
Awarded Honorable Mention for the Arnold R. Weitz, M.D. Memorial Prize in Hematology, 2014
Publications
Selected Publications
Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies. Nakhoda SK, Olszanski AJ. Pharmaceut Med. 2020 Apr;34(2):83-91. doi: 10.1007/s40290-020-00326-z. PMID: 32157638
Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Nakhoda S, Zimrin AB, Baer MR, Law JY. Transfus Apher Sci. 2017 Apr;56(2):123-126. doi: 10.1016/j.transci.2016.10.005. Epub 2016 Oct 17. PMID: 27789124 Clinical Trial.
Additional Publications
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Treatment Philosophy
Navigating a new cancer diagnosis can be challenging and overwhelming. I feel honored to be part of a team that provides patients and their families not only specialized oncologic care, but also the support and resources needed. The collaborative network of clinicians, nurses, and researchers at Fox Chase allows me to provide my patients individualized treatment options, novel therapies, and access to clinical trials. In addition, I strive to provide my patients and their families compassionate and comprehensive clinical care throughout each aspect of their journey.
Education
Educational Background
- Hematology & Oncology Fellowship Training, Temple University and Fox Chase Cancer Center, Philadelphia, PA, 07/2017-06/2020
- Internal Medicine Residency Training, University of Maryland Medical Center, Baltimore, MD, 6/2014-06/2017
- MD, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, 2014
Certifications
American Board of Internal Medicine
Memberships
- American Society of Clinical Oncology
- American Society of Hematology
Honors & Awards
Awarded Honorable Mention for the Arnold R. Weitz, M.D. Memorial Prize in Hematology, 2014
Publications
Selected Publications
Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies. Nakhoda SK, Olszanski AJ. Pharmaceut Med. 2020 Apr;34(2):83-91. doi: 10.1007/s40290-020-00326-z. PMID: 32157638
Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Nakhoda S, Zimrin AB, Baer MR, Law JY. Transfus Apher Sci. 2017 Apr;56(2):123-126. doi: 10.1016/j.transci.2016.10.005. Epub 2016 Oct 17. PMID: 27789124 Clinical Trial.